All Sauce from Weekly Sauce:

(HealthDay News) – Danish drugmaker Novo Nordisk said Thursday it will limit distribution of its low-dose versions of the wildly popular weight-loss drug Wegovy, to ensure that people already taking the drug will have enough supply. The medication is one of three drugs from a class known as GLP-1 agonists. These medications have been shown…  read on >  read on >

Four symptoms could provide early warning of colon cancer in younger adults. Being aware of these red flags could lead to earlier detection and diagnosis for those under age 50, said researchers at Washington University School of Medicine in St. Louis. The telltale symptoms are abdominal pain, rectal bleeding, diarrhea and iron deficiency anemia. The…  read on >  read on >

While public health officials have expressed concerns about teens vaping, a new study suggests getting more to quit may be simple. Eliminating flavored e-cigarettes may reduce the use of vapes altogether in teens and young adults, the research found. “The restriction of the availability for certain e-cigarette e-liquid flavors has been considered by various regulatory…  read on >  read on >

Hundreds of thousands of people are jumping on the Ozempic bandwagon and taking prescription medications to slim down, while others swear by intermittent fasting and other diet fads, but new research shows that they’re all likely barking up the wrong trees. There isn’t any shortcut or magic bullet to losing weight, keeping it off, and…  read on >  read on >

It’s standard for heart attack survivors to take beta blocker medications for years afterward, but a new study suggests that may be unnecessary for people who’ve had a milder heart attack. Researchers found that among heart attack survivors whose hearts still had normal pumping ability, there was no added benefit from using beta blockers for…  read on >  read on >